TWi Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Cyclobenzaprine | Cyclobenzaprine | 2013-01-31 | ||
| Dexlansoprazole | Dexlansoprazole | 2022-09-16 | 2026-2032 | |
| Diclofenac | Diclofenac | 2014-11-24 | 2026-2035 | |
| Diltiazem | Diltiazem | 2018-08-30 | ||
| Dimethylfumarate | Dimethylfumarate | 2020-10-14 | 2028-2035 | |
| Donepezil | Donepezil | 2014-10-29 | 2025-2038 | |
| Fluphenazine | Fluphenazine | 2022-04-01 | ||
| Guanfacine | Guanfacine | 2015-06-02 | ||
| Megestrol | Megestrol | 2014-08-27 | 2024 | |
| Metformin | Metformin | 2021-09-29 | 2023-2035 | |
| Mycophenolic | Mycophenolic | 2021-11-03 | ||
| Nifedipine | Nifedipine | 2014-04-03 | ||
| Terbutaline | Terbutaline | 2020-06-19 |
1
2
3
>
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use